Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations

Autor: Group, Milena Sant, Maria Chiara Magri, Andrea Maurichi, Roberto Lillini, Maria José Bento, Eva Ardanaz, Marcela Guevara, Kaire Innos, Rafael Marcos-Gragera, Jordi Rubio-Casadevall, Maria-José Sánchez Pérez, Rosario Tumino, Massimo Rugge, Pamela Minicozzi, the Melanoma HR Study Working Group the Melanoma HR Study Working

Publikováno v: Cancers; Volume 14; Issue 18; Pages: 4379

Objectives: Standard care for cutaneous melanoma includes an accurate pathology report (PR) and sentinel lymph node biopsy (SLNB) for staging clinically node-negative >1 mm melanomas. We aimed to investigate the frequency of these indicators across E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::621e1ab9b6968214563b6c26d3d5980e

Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations.

Autor: Sant M; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Magri MC; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Maurichi A; Melanoma and Sarcoma Surgical Unit, Foundation IRCCS National Cancer Institute, 20133 Milan, Italy., Lillini R; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Bento MJ; North Region Cancer Registry of Portugal (RORENO), Cancer Epidemiology Group, IPO Porto Research Center, 4200-072 Porto, Portugal.; Department of Population Studies, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4200-465 Porto, Portugal., Ardanaz E; Navarre Public Health Institute, 31006 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Navarre Institute for Health Research (IdiSNA), 31006 Pamplona, Spain., Guevara M; Navarre Public Health Institute, 31006 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Navarre Institute for Health Research (IdiSNA), 31006 Pamplona, Spain., Innos K; Department of Epidemiology and Biostatistics, National Institute for Health Development, 11619 Tallinn, Estonia., Marcos-Gragera R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdiBGi), 08908 Girona, Spain., Rubio-Casadevall J; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdiBGi), 08908 Girona, Spain., Sánchez Pérez MJ; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Andalusian School of Public Health (EASP), Granada Cancer Registry, 18011 Granada, Spain.; The Biomedical Research Institute (ibs.GRANADA), 18014 Granada, Spain.; Department of Preventive Medicine and Public Health, University of Granada, 18011 Granada, Spain., Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), 97100 Ragusa, Italy., Rugge M; Department of Medicine-DIMED, Surgical Pathology and Cytopathology Unit, Università degli Studi di Padova, 35139 Padova, Italy., Minicozzi P; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK., The Melanoma Hr Study Working Group

Publikováno v: Cancers [Cancers (Basel)] 2022 Sep 08; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 08.